Strategies for preventing type I diabetes mellitus

Western Journal of Medicine

Volumn 164, Issue 3, 1996, Pages 249-255

  Verge, Charles F ^a   Eisenbarth, George S ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; C PEPTIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; INSULIN; INSULIN ZINC SUSPENSION; NICOTINAMIDE; PANCREAS ISLET CELL ANTIBODY; PLACEBO; PREDNISONE;

ANIMAL MODEL; ANTIBODY TITER; AUTOIMMUNITY; CHROMOSOME 11; CHRONIC DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FAMILY STUDY; GENE LOCUS; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INTRAVENOUS DRUG ADMINISTRATION; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR CLINICAL STUDY; NONHUMAN; ORAL DRUG ADMINISTRATION; SCREENING TEST; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; HUMANS; ISLETS OF LANGERHANS; PREDIABETIC STATE;

EID: 0030000646     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (99)

1. Eisenbarth GS: Type 1 diabetes mellitus A chronie autoimmune disease N Engl J Med 1986, 314:1360-1368
2. Tillil H, Kobberling J: Age-correlated empirical genetic risk estimates for first degree relatives of IDDM patients. Diabetes 1987, 36:93-99
3. Bonifacio E, Bingley PJ, Shattock M, et al: Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes Lancet 1990; 335:147-149
4. Riley WJ, Maclaren NK, Krischer J, et al: A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 1990, 323 1167-1172
5. Snkanta S, Ganda OP, Soeldner JS, Eisenbarth GS First degree relatives of patients with type I diabetes mellitus: Islet cell antibodies and abnormal insulin secretion. N Engl J Med 1985; 313 461-464
6. Davies JL, Kawaguchi Y, Bennett ST, et al: A genome-wide search for human type I diabetes susceptibility genes. Nature 1994, 371 130-136
7. Thomson G, Robinson WP, Kuhner MK, et al: Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus Am J Hum Genet 1988; 43:799-816
8. Bodmer JG, Marsh SGE, Albert ED, et al: Nomenclature for factors of the HLA system. 1995. Hum Immunol 1995, 43:149-164
9. Fletcher J, Mijovic C, Odugbesan O, Jenkins D, Bradwell AR, Barnett AH: Trans-racial studies implicate HLA-DQ as a component of genetic susceptibility to type I (insulin-dependent) diabetes. Diabetologia 1988, 31.864-870
10. Todd JA, Mijovic C, Fletcher J, Jenkins D, Bradwell AR, Barnett AH: Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping. Nature 1989; 338:587-589
11. Jenkins D, Mijovic C, Fletcher J, Jacobs KH, Bradwell AR, Bamett AH: Identification of susceptibility loci for type I (insulin-dependent) diabetes by transracial gene mapping. Diabetologia 1990; 33.387-395
12. Rønningen KS, Spurkland A, Iwe T, Vandal F, Thorsby E: Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Nonvegian patients with insulin-dependent diabetes mellitus. Tissue Antigens 1991, 37:105-111
13. Bugawan L, Erlich HA: Rapid typing of HLA-DQB1 DNA polymorphism using nonradioactive oligonucleotide probes and amplified DNA. Immunogenetics 1991; 33:163-170
14. Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, Capra JD Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med 1990, 322.1836-1841
15. Pugliese A, Gianani R, Moromisato R, et al: HLA-DQB 1*0602 is associated with dominant protection from diabetes even among islet cell antibody positive first degree relatives of patients with insulin-dependent diabetes Diabetes 1995; 44:608-613
16. Bell GI, Horita S, Kararn JH; A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes meilltus Diabetes 1984; 33 176-183
17. Julier C, Hyer RN, Davies J, et al: Insulin-IGF2 region encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature 1991, 354: 155-159
18. Bennett ST, Lucassen AM, Gough SCL. et al: Susceptibility to human type I diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nature Genet 1995, 9:284-292
19. Olmos P, A'Hern R, Heaton DA, et al: The significance of concordance rate for type I (insulin-dependent) diabetes mellitus in identical twins Diabetologia 1988; 31:747-750
20. Kaprio J, Tuomilehto J, Koskenvuo M, et al: Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus, in a population-based cohort of twins in Finland. Diabetologia 1992; 35.1060-1067
21. Verge CF, Gianani R, Yu L, et al: Late progression to diabetes and evidence for chronic beta cell autoimmunity in identical twins of patients with type I diabetes Diabetes 1995; 44:1176-1179
22. Bodansky HJ, Staines A, Stephenson C, Haigh D, Cartwright R, Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population. Br Med J 1992; 304:1020-1022
23. Elliott RB, Pilcher C, Edgar BW: Geographic IDDM in Polynesia and Macronesia: The Epidemiology of Insulin Dependent Diabetes in Polynesian Children Born and Reared in Polynesia, Compared With Polynesian Children Resident in Auckland, New Zealand - Diabetes in the Young Bulletin. Proceedings of the International Study Group for Diabetes (Abstr) 1989, 20: 16
24. Rewers M, LaPorte RE, Walczak M, Dmochowski K, Bogaczynska E: Apparent epidemic of insulin-dependent diabetes mellitus in midwestern Poland. Diabetes 1987; 36:106-113
25. Green A, Andersen PK, Svendsen AJ, Mortensen K: Increasing incidence of early onset type I (insulin-dependent) diabetes mellitus: A study of Danish male birth cohorts Diabetologia 1992, 35.178-182
26. Tuomilehto J, Rewers M, Reunanen A, et al: Increasing trend in type I (insulin-dependent) diabetes mellitus in childhood in Finland: Analysis of age, calendar time. and birth cohort effects during 1965 to 1984. Diabetologia 1991; 34:282-287
27. Joner G, Søvik O: Increasing incidence of diabetes mellitus in Norwegian children 0-14 years of age 1973-1982. Diabetologia 1989, 32:79-83
28. Nystrom L, Dahlquist G, Rewers M, Wall S: The Swedish childhood diabetes study - An analysis of the temporal variation in diabetes incidence, 1978-1987. Int J Epidemiol 1990; 19.141-146
29. Soltész G, Madácsy L. Békefi D, Dankó I: Rising incidence of type 1 diabetes in Hungarian children (1978-1987) - Hungarian Childhood Diabetes Epidemiology Group. Diabetic Med 1989; 7.111-114
30. Drykoningen CEM, Mulder ALM, Vaandrager GJ, LaPorte RE, Bruining GJ: The incidence of male childhood type I (insulin-dependent) diabetes mellitus is rising rapidly in The Netherlands. Diabetologia 1992; 35:139-142
31. Menser MA, Forrest JM, Bransby RD: Rubella infection and diabetes mellitus. Lancet 1978, 1 57-60
32. Karounos DG, Simmerman L, Hickman SL, Jacob RJ. Identification of the p52-rubella related autoantigen as an insulin secretory granule protein (Abstr). Diabetes 1993, 42(suppl 1):221A
33. Clarke WL, Shaver KA, Brighi GA, Rogal AD, Nance WE: Autoimmunity in congenital rubella syndrome. J Pediatr 1984; 104:370-373
34. Rabinowe SL, George KL, Laughlin R, Soeldner JS, Eisenbarth GS, Congenital rubella: Monoclonal antibody-defined T cell abnormalities in young adults. Am J Med 1986; 81:779-782
35. Oldstone M, Nerenberg M, Southern P, Pnce J, Lewicki H: Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of antiself (virus) immune response. Cell 1991; 65:319-331
36. Yoon JW, Austin M, Onodera T, Notkins AL, Virus-induced diabetes mellitus. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979; 300:1173-1179
37. Ohashi PS, Oehen S, Buerki K, et al: Ablation of 'tolerance' and induction of diabetes bv virus infection in viral antigen transgenic mice. Cell 1991; 65: 305-317
38. Yoon JW; Role of viruses in the pathogenesis of IDDM. Ann Med 1991; 23:437-445
39. Oldstone MBA: Prevention of type 1 diabetes in nonobese diabetic mice by vints infection Science 1988, 239:500-502
40. McInerney MF, Pek SB, Thomas DW: Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice. Diabetes 1991: 40:715-725
41. Shehadeh N, Calcinaro F, Bradley BJ, Bruchlim I, Vardi P, Lafferty KJ: Effect of adjuvant therapy on development of diabetes in mouse and man Lancet 1994, 343:706-707
42. Qin H, Sadelain MWJ, Hitchon C, Lauzon J, Singh B: Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in non-obese diabetic mice J Immunol 1993; 150:2072-2080
43. Yagi H, Matsumoto M, Suzuki S, et al: Possible mechanism of the preventive effect of BCG against diabetes mellitus in NOD mouse - I. Generation of suppressor macrophages in spleen cells of BCG-vaccmated mice. Cell Immunol 1991; 138:130-141
44. Yagi H, Matsumoto M, Kishimoto Y, Makino S, Harada M: Possible mechanism of the preventive effect of BCG against diabetes mellitus in NOD mouse - II Suppression of pathogenesis by macrophage transfer from BCG-vaccinated mice Cell Immunol 1995; 138-142-149
45. Virtanen SM, Rasanen L, Aro A, et al: Infant feeding in Finnish children < 7 yr of age with newly diagnosed IDDM. Diabetes Care 1991, 14.415-417
46. Verge CF, Howard NJ, Irwig L, Simpson JM, Mackerras D, Silink M. Environmental factors in childhood IDDM: A population-based, case-control study. Diabetes Care 1994; 17 1381-1389
47. Mayer EJ, Hamman RF, Gay EC, Lezotte DC, Savitz DA, Klingensmith GJ. Reduced risk of IDDM among breast-fed children - The Colorado IDDM registry. Diabetes 1988; 37:625-1632
48. Kostraba JN, Cruickshanks KJ, Lawler-Heavner J, el al: Early exposure to cow's milk and solid foods in infancy, genetic predisposition, and risk of IDDM. Diabetes 1993; 42:288-295
49. Elliott RB, Martin JM Dietary protein: A trigger of insulin-dependent diabetes in the BB rat? Diabetologia 1984; 26:297-299
50. Ziegler AG, Hillebrand B, Rabl W, et al: On the appearance of islet associated autoimmunity in offspring of diabetic mothers: a prospective study from birth Diabetologia 1993; 36:402-408
51. Akerblom HK, Paganus A, Teramo K, et al: Primary prevention of type 1 diabetes by nutritional intervention - Description of a pilot study (Abstr). Autoimmunity 1993: 15(suppl):58
52. Wegman DR, Norbury-Glaser M, Daniel D: Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur J Immunol 1994; 24,1853-1857
53. Kaufman DL, Clare-Salzler M, Tian J, et al: Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993, 366.69-72
54. Tisch R, Yang X, Singer SM, Liblau RS, Fugger L, McDevitt HO Immune response to glutamic acid decarboxylase correlates with insulitis in nonobese diabetic mice. Nature 1993, 366:72-75
55. Srikanta S, Ganda OP, Eisenbarth GS, Soeldner JS: Islet cell antibodies and beta-cell function in monozyaotic triplets and twins initially discordant for type I diabetes mellitus. N Engl J Med 1983, 308:322-325
56. Greenbaum CJ, Palmer JF, Nagataki S, et al: Improved specificity of ICA assays in the Fourth International Immunology of Diabetes Exchange Workshop Diabetes 1992; 41:1570-1574
57. Landin-Olsson M: Precision of the islet-cell antibody assay depends on the pancreas J Clin Lab Anal 1990, 4:289-294
58. Palmer JP, Asplin CM, Clemons P, et al: Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222:1337-1339
59. Baekkeskov S, Aanstoot HJ, Chnstgau S, et at: Identification of the 64K autoantigen in insulin dependent diabetes as the GABA-symhesizing enzyme glutamic acid decarboxylase Nature 1990, 347:151-156
60. Rabin DU, Pleasic SM, Shapiro JA, et al: Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases J Immunol 1994; 152:3183-3188
61. Lan MS, Lu J, Goto Y, Notkins AL: Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, LA-2, from human insulinoma. DNA Cell Biol 1994; 13.505-514
62. Gianani R, Yu L, Verge CF, Babu S, Pietropaolo M, Eisenbarth GS: Recombinant ICA512 radioassay (Abstr) J Invest Med 1995;43(suppl):331A
63. Gianani R, Pugliese A, Bonner-Weir S, et al. Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes Diabetes 1992; 41 347-353
64. Genovese S, Bonifacio E, MeNally JM, et al: Distinct cytoplaimic islet cell antibodies with different risks for type I (insulin-dependent) diabetes mellitus. Diabetologia 1992; 35:385-388
65. Gianani R, Jackson R, Eisenbarth GS: Evidence that the autoantigen of restricted ICA is GAD (Abstr). Diabetes Res Clin Pract 1991; 14(suppl 1):SI3
66. Yamada K, Nonaka K, Hanafusa T, Miyazaki A, Toyoshima H, Tarui S: Preventive and therapeutic aspects of large-dose nicotinamide injections on diabetes associated with insulitis: An observation in non-obese diabetic (NOD) mice. Diabetes 1982; 31.749-753
67. Hermine L, Vialettes B, Atlef N, et al: High dose nicotinamide fails to prevent diabetes in BB rats. Autoimmunity 1989, 5:79-86
68. Vague P, Picq R, Bernal M, Lassmann-Vague V, Vialettes B: Effect of nicotinamide treatment on the residual insulin secretion in type I (insulin-dependent) diabetic patients. Diabetologia 1989; 32.316-321
69. Mendola G, Casamitjana R, Gomis R, Effect of nicotinamide therapy upon B-cell function in newly diagnosed type 1 (insulin-dependent) diabetic patients. Diabetoaogia 1989; 32:160-162
70. Chase HP, Butler-Simon N, Garg S, McDuffie M, Hoops SL, O'Brien D: A trial of nicotinamide in newly diagnosed patients with type 1 (insulin-dependent) diabetes mellitus, Diabetologia 1990; 33.444-446
71. Lewis CM, Canafax DM, Sprafka JM, Barbosa JJ, Double-blind randomized trial of nicotinamide on early-onset diabetes. Diabetes Care 1992; 15:121-123
72. Herskowitz RD, Jackson RA, Soeldner JS, Eisenbarth GS Pilot trial to prevent type I diabetes. Progression to overt IDDM despite oral nicotinamide. J Autoimmunity 1989; 2 733-737
73. Elliott RB, Chase HP: Prevention or delay of type I (insulin-dependent) diabetes mellitus in children using nicotinamide. Diabetologia 1991, 34:362-365
74. Elliott RB, Pilcher CC, McGregor MA: Protection from diabetes in normal school children using nicotinamide (Abstr) Autoimmunity 1993; 15 (suppl):57
75. Zhang JZ, Davidson L, Eisenbarth GS, Weiner HL: Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 1991; 88:10252-10256
76. Thompson HSG, Staines NA: Could specific oral tolerance be a therapy for autoimmune disease? Immunol Today 1990;11:396-399
77. Chen Y, Inobe J, Marks R, Gonnella P, Kuchroo VK, Weiner HL: Peripheral deletion of antigen-reactive T cells in oral tolerance Nature 1995; 376: 177-180
78. Weiner HL, Mackin GA, Matsui M, et al: Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 1993; 259: 1321-1324
79. Bingley PJ, Colman P, Eisenbarth GS, et al: Standardization of IVGTT to predict IDDM. Diabetes Care 1992, 15:1313-1316
80. Colman PG, Stewart V, Kean J, et al: Comparison of two commonly used standard IVGTTs. Diabetes Care 1992; 15:1053-1055
81. Allen HF, Jeffers BW, Klingensmith GJ, Chase HP, First-phase insulin release in normal children. J Pediatr 1993; 123:733-738
82. Carel JC, Boitard C, Bougneres PF: Decreased insulin response to glucose in islet cell antibody-negative siblings of type 1 diabetic children. J Clin Invest 1993; 92:509-513
83. Arslanian S, Austin A: Determinants of first and second phase insulin secretion in healthy adolescents (Abstr). Pediatr Res 1993; 3(suppl):S74
84. Vardi P, Crisa L, Jackson RA: Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type I (insulin-dependent) diabetic patients. Diabetologia 1991; 34:93-102
85. Muir A, Peck A, Clare-Salzler M, et al: Insulin immunization of nonobese diabetic mice induces a protective insulitus characterized by diminished intraislet interferon-gamma transcription. J Clin Invest 1995; 95:628-634
86. Gotfredsen CF, Buschard K, Frandsen EK: Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia 1985; 28:933-935
87. Björk E, Kämpe O, Andersson A, Karlsson FA: Expression of the 64 kDa/glutamic acid decarboxylase rat islet cell autoantigen is influenced by the rate of insulin secretion Diabetologia 1992; 32:490-493
88. Elliott RB, Bibby NJ, Ambler G: Prevention of diabetes in the NOD mouse by insulin is unrelated to its metabolic effect (Abstr). Autoimmunity 1993; 15(suppl):71
89. Shah SC, Malone JI, Simpson NE: A randomized trial of intensive insulin therapy in newly diasnosed insulin-dependent diabetes mellitus. N Engl J Med 1989;320:550-554
90. Keller RJ, Eisenbarth GS, Jackson RA, Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet 1993; 341.927-928
91. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28:1039-1057
92. McCulloch DK, Koerker DJ, Kahn SE, Bonner-Weir S, Palmer JP: Correlations of in vivo beta-cell function tests with beta-cell mass and pancreatic insulin content in streptozocin-treated baboons. Diabetes 1991; 40:673-679
93. Feutren G, Papoz L, Assan G, et al: Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset - Results of a multicentre double-blind trial. Lancet 1986; 2:119-124
94. Dupre J, Jenner MR, Mahon JL, Purdon C, Rodger NW, Stiller CR: Endocrine-metabolic function in remission-phase IDDM during administration of cyclosporine Diabetes 1991; 40 598-604
95. Martin S. Schernthaner G, Nerup J, et al: Follow-up of cyclosporin A treatment in type I (insulin-dependent) diabetes mellitus: Lack of long-term effects. Diabetologia 1991; 34:429-434
96. Bougnères PF, Landais P, Boisson C, et al: Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporine. Diabetes 1990; 39:1264-1272
97. Cook JJ, Hudson I, Harrison LC, et al. Double blind controlled trial of azathioprine in children with newly diagnosed type I diabetes. Diabetes 1989; 38. 779-783
98. Silverstein J, Maclaren N, Riley W, Spillar R, Radjenovic D, Johnson S: Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus, N Engl J Med 1988; 319:599-604
99. Schatz D, Krischer J, Horne G, et al: Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives J Clin Invest 1994; 93:2403-2407